Wallace & Graham

Winning justice on behalf of hardworking people is what Wallace & Graham’s attorneys are all about.

Drugs and Medical Devices

CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR) — FDA issues a safety warning related to diabetes medicine and amputations

Updated June 19, 2017 In the News: Drug Safety                                                         FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR)  On March 16, 2017, the Food and Drug Administration…

INACCURATE LEAD TESTING KITS

In the News: INACCURATE LEAD TESTING KITS May 18, 2017 The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are warning Americans that some Lead testing systems may provide inaccurate results. The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) warning that all four of Magellan Diagnostics’ lead…

FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR)

In the News: Drug Safety May 18, 2017 FDA issues a safety warning related to diabetes medicine CANAGLIFLOZIN (Invokana, Invokamet, Invokamet XR) On March 16, 2017, the Food and Drug Administration (FDA) issued a Drug Safety Announcement related to the diabetes medicine CANAGLIFLOZIN based on data from two large clinical trials. CANAGLIFLOZIN is used to treat individuals with type 2…